Perivascular Cav-1 expression is considered as a marker for distinguishing benign from malignant uterine smooth muscle tumors given that perivascular Cav-1 is more expressed in leiomyosarcomas compared with uncertain malignant potentials and leiomyomas (Ayaz et al., 2016). This evidence concerns the gene CAV1 and leiomyoma.